BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18028530)

  • 1. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.
    Tidey JW; Monti PM; Rohsenow DJ; Gwaltney CJ; Miranda R; McGeary JE; MacKillop J; Swift RM; Abrams DB; Shiffman S; Paty JA
    Alcohol Clin Exp Res; 2008 Jan; 32(1):58-66. PubMed ID: 18028530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic moderators of naltrexone's effects on alcohol cue reactivity.
    McGeary JE; Monti PM; Rohsenow DJ; Tidey J; Swift R; Miranda R
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1288-96. PubMed ID: 16899031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.
    Ray LA; Miranda R; Tidey JW; McGeary JE; MacKillop J; Gwaltney CJ; Rohsenow DJ; Swift RM; Monti PM
    J Abnorm Psychol; 2010 Feb; 119(1):115-25. PubMed ID: 20141248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
    Anton RF; Voronin KK; Randall PK; Myrick H; Tiffany A
    Alcohol Clin Exp Res; 2012 Nov; 36(11):2000-7. PubMed ID: 22551036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.
    Kranzler HR; Armeli S; Covault J; Tennen H
    Addict Biol; 2013 Jan; 18(1):193-201. PubMed ID: 22784013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration.
    Lechner WV; Knopik VS; McGeary JE; Spillane NS; Tidey JW; McKee SA; Metrik J; Leventhal AM; Rohsenow DJ; Kahler CW
    Nicotine Tob Res; 2016 May; 18(5):632-6. PubMed ID: 26092968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
    Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
    Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics.
    Rohsenow DJ; Miranda R; McGeary JE; Monti PM
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):272-81. PubMed ID: 17563214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
    Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
    Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.
    Bujarski S; MacKillop J; Ray LA
    Exp Clin Psychopharmacol; 2012 Jun; 20(3):181-90. PubMed ID: 22429255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid antagonists for alcohol dependence.
    Srisurapanont M; Jarusuraisin N
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
    Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of naltrexone on alcohol self-administration in heavy drinkers.
    Davidson D; Palfai T; Bird C; Swift R
    Alcohol Clin Exp Res; 1999 Feb; 23(2):195-203. PubMed ID: 10069545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation.
    Ray LA; Hutchison KE; Ashenhurst JR; Morrow AL
    Alcohol Clin Exp Res; 2010 Aug; 34(8):1479-87. PubMed ID: 20528823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.